69249-13-4 Usage
Description
4-(PIPERAZIN-1-YLSULFONYL)ANILINE is a chemical compound that features a piperazine ring, a sulfonamide group, and an aniline ring. It is recognized for its significance as an intermediate in the synthesis of pharmaceuticals and agrochemicals, with the piperazine group often present in drugs with antihistamine, antipsychotic, and antiemetic properties, and the sulfonamide group known for its antibacterial and diuretic properties.
Used in Pharmaceutical Industry:
4-(PIPERAZIN-1-YLSULFONYL)ANILINE is used as a key intermediate for the synthesis of various drugs due to its piperazine functional group, which is prevalent in medications with antihistamine, antipsychotic, and antiemetic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 4-(PIPERAZIN-1-YLSULFONYL)ANILINE is utilized as an intermediate in the production of compounds with potential applications in agriculture, taking advantage of its sulfonamide group known for antibacterial and diuretic properties.
Overall, 4-(PIPERAZIN-1-YLSULFONYL)ANILINE has a broad spectrum of potential uses in the creation of bioactive compounds across different industries, highlighting its importance in both pharmaceutical and agrochemical development.
Check Digit Verification of cas no
The CAS Registry Mumber 69249-13-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,2,4 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 69249-13:
(7*6)+(6*9)+(5*2)+(4*4)+(3*9)+(2*1)+(1*3)=154
154 % 10 = 4
So 69249-13-4 is a valid CAS Registry Number.
69249-13-4Relevant articles and documents
CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS
-
Page/Page column 172; 203, (2021/11/26)
This invention is in the area of cell cycle inhibiting compounds for the treatment of disorders involving abnormal cellular proliferation, and include selective CDK2 inhibitors for medical therapy and their pharmaceutically acceptable salts and compositions.
